Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Dupilumab can improve both atopic dermatitis and alopecia universalis.

Blocking androgen receptors boosts macrophages' ability to clear certain bacteria.

Remote monitoring of chronic diseases like dermatomyositis is challenging and needs better tools for early detection and patient education.

Blocking miR-27a increases sheep hair follicle stem cell growth and decreases cell death, which could help improve wool quality and treat hair loss.

CS12192 effectively treats alopecia areata with better safety than current options.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Metformin may help treat neuroendocrine tumors.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

New cytokine-targeted therapies show promise for treating alopecia areata.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Two women experienced temporary hair loss and other side effects from imiquimod treatment for cervical issues, which stopped after ending the treatment.

Tofacitinib might be used to treat hair loss.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.